Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.

Abstract: A boron nitride composite is proposed. The boron nitride composite may include an aggregate including a plurality of boron nitride particles bonded to each other to form a plurality of pores. The boron nitride composite may also include a filler containing at least one of an organic material or an inorganic material, and filled in at least some of the plurality of pores such that the organic material and the inorganic material do not cover an outer surface of the aggregate.

Abstract: Provided are a method for manufacturing conglomerated graphite, the conglomerated graphite manufactured using the method, and a secondary battery including the conglomerated graphite as an anode active material. Particularly, provided are a method for producing conglomerated graphite having a small specific surface area for excellent initial efficiency and excellent high power of a secondary battery using natural graphite, the conglomerated graphite produced using the method, and a secondary battery including the conglomerated graphite as an anode active material.

Abstract: The present disclosure relates generally to methods of preparing glycoconjugates containing a saccharide conjugated to a carrier protein by use of stable nitroxyl radical related agent/oxidant as an oxidizing agent, to immunogenic compositions comprising such glycoconjugates, and to methods for the use of such glycoconjugates and immunogenic compositions.

Abstract: An operation method of an application system includes receiving a chat room-entry event notifying that a user enters the chat room from a terminal in which an application is installed, generating an entry trigger based on the chat room enter event, and providing user context suitable information inferred based on a user key included in the entry trigger to the chat room.

Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.

Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.

Abstract: An operation method of an application system includes receiving a chat room-entry event notifying that a user enters the chat room from a terminal in which an application is installed, generating an entry trigger based on the chat room enter event, and providing user context suitable information inferred based on a user key included in the entry trigger to the chat room.

Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.

Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.

Abstract: A multilayer electronic component includes first and second internal electrodes alternately disposed with the dielectric layer interposed therebetween and connected to first and second external electrodes, respectively, in which the first and second internal electrodes include first and second bend portions, respectively, bent in margin regions of a body adjacent to third and fourth surfaces of the body, respectively. The present disclosure is intended to control an angle of the first and second bent portions so that the moisture resistance reliability of the multilayer electronic component is not reduced even if the bent portion is formed in a region in which the first internal electrode is adjacent to the third surface and a region in which the second internal electrode is adjacent to the fourth surface.

Abstract: A battery management apparatus includes a processor and memory having programmed thereon instructions that, when executed, are configured to cause the processor to, for each battery pack of the plurality of battery packs connected in parallel, measure a voltage and a current of the battery pack, calculate a voltage difference between both terminals of at least one relay of the battery pack, based on the measured voltage of the battery pack, and control an operation of the at least one relay included in the battery pack and determine whether any of the one or more relays of any of the plurality of battery packs is stuck, based on respective operations of the one or more relays included in the plurality of battery pack, the respective voltage differences of the one or more relays include in the plurality of battery packs, and the measured currents of the plurality of battery packs.

Abstract: A light irradiation device includes: a mount part having a slide rail; a slide part connected to the mount part and configured to slide along the slide rail; and an optical module provided on one side of the slide part to irradiate light onto a user's body. The slide part includes: a lower slide housing; an upper slide housing coupled to an upper portion of the lower slide housing; and a roller assembly having one side coupled to the upper slide housing and the other side penetrating the lower slide housing and connected to the slide rail.

Abstract: A light irradiation device includes: a mount part having a slide rail; a slide part connected to the mount part and configured to slide along the slide rail; and an optical module provided on one side of the slide part to irradiate light onto a user's body. The mount part includes: a body part; a connection bracket detachably coupled to the body part; a lower mount housing coupled to the connection bracket; and an upper mount housing coupled to the slide rail, and having a slide slit formed to expose the slide rail to the outside.

Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in Prevnar, Synflorix and/or Prevnar 13. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said novel immunogenic compositions.

Abstract: Disclosed is a method of processing item sales information by an electronic apparatus including acquiring a purchase request including item information related to an item selected by a user and information related to a payment means, providing a purchase response including approval information corresponding to the purchase request before proceeding with payment through the payment means in response to the purchase request when the information related to the payment means satisfies a first condition, transmitting a release request for the item to a first server; and requesting payment for at least some of an amount corresponding to one or more purchase requests related to the payment means according to an arrival of settlement timing corresponding to the payment means.

Abstract: The present invention provides an optical filter having a narrow bandpass, high transmittance in the bandpass, low transmittance outside the bandpass, little change in optical properties even when the incident angle of light changes and thus, being advantageous in terms of yield and cost per hour. In addition, the present invention may provide a LiDAR system including the optical filter and an application of the optical filter and the LiDAR system.

Abstract: A cooking appliance includes a casing having a cavity and an electric chamber therein, and a door disposed in front of the casing to open and close the cavity. A cooling fan module is disposed at the electric chamber, and sucks external air and discharges air to an exhaust port in front of the casing. A bottom spacer protrudes from the casing, and the bottom spacer spaces a lower surface of the casing and a seating surface on which the casing is seated from each other to form an intake port. A first air flow path is formed at the lower portion of the casing so that air introduced through the intake port flows to a rear space of the casing, and a second air flow path connecting the first air flow path and the electric chamber to each other may be formed at the rear space of the casing.

Abstract: The present invention relates generally to glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a spacer containing ((2-oxoethyl)thio)). In an aspect the invention provides oxo-eT linked glycoconjugates comprising a saccharide covalently conjugated to a carrier protein through a ((2-oxoethyl)thio) spacer having the formula (I): wherein: A is a group (C?X)m wherein X is S or O and m is 0 or 1; B is a bond, O, or CH2; and when m is 0, B can also be (C?O); R is a C2-C16 alkylene, C2-C16 heteroakylene, NH—C(?O)—C2-C16 alkylene, or NH—C(?O)—C2-C16 heteroakylene, wherein said alkylene and heteroalkylene are optionally substituted by 1, 2 or 3 groups independently selected from COOR? where R? is selected from H, methyl, ethyl or propyl. The invention further relates to immunogenic compositions comprising such glycoconjugates, and to methods for the preparation and use of such glycoconjugates and immunogenic compositions.

Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.